ORIC is a research-driven company dedicated to discovering and developing novel therapies that can Overcome Resistance In Cancer. Our collaborative, empowering culture gives scientists the authority, responsibility, and support to do cutting-edge work on therapies for treatment-resistant cancers. Our culture and values support our mission, provide a shared understanding of how we work together as a company and provide a clear sense of what is most important for us as an organization.
Responsibilities:
- Accountable for the design, development, and characterization of phase appropriate solid oral dose drug product formulations, packaging, and manufacturing processes to successfully support clinical studies.
- Leading the cGMP drug product manufacturing and packaging activities at CMOs and oversight in close partnership with quality.
- Lead late-stage drug product development activities including scale-up, design of experiments (DOEs), risk assessments, and development of the integrated control strategy in partnership with other CMC functional areas, Quality, Regulatory Affairs, and Manufacturing.
- Leading the developability assessment of new candidates, preclinical formulation, preformulation, and discovery pharmaceutics studies including API form selection and characterization to nominate a suitable form for development, troubleshooting, and ‘defining the path’ for new drug candidates.
Qualifications :
- Ph.D. or M.S. in Chemical Engineering or relevant scientific discipline with at least 10 years of experience in Formulation and Drug product development and track record of progressing assets from INDs to MAAs.
- Strong understanding and extensive hands‐on experience in early- and late-stage drug product process development. In-depth understanding of formulation development best practices & trends.
- Proven experience in the generation of relevant regulatory sections of IND filings.
- Excellent problem-solving and decision-making skills with the ability to quickly adapt to changing program needs